These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 768950)

  • 1. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):66-71. PubMed ID: 768950
    [No Abstract]   [Full Text] [Related]  

  • 2. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract]   [Full Text] [Related]  

  • 3. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 4. Gemfibrozil treatment: a comparison with clofibrate.
    Howard AN; Ghosh P
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
    Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
    Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid lowering drugs and hyperlipidaemia.
    Levy RI; Rifking BM
    Drugs; 1973; 6(1):12-45. PubMed ID: 4361281
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of hyperlipidemia.
    Lees RS; Wilson DE
    N Engl J Med; 1971 Jan; 284(4):186-95. PubMed ID: 4923684
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial of methyl clofenapate (a derivative of clofibrate) in patients with essential hyperlipidaemias--with special reference to type II (primary) hyperlipidaemia.
    Craig GM; Walton KW
    Atherosclerosis; 1972; 15(2):189-98. PubMed ID: 4579956
    [No Abstract]   [Full Text] [Related]  

  • 9. Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
    Davignon J; Aubry F; Noël C; Lapierre Y; Lafortune M
    Rev Can Biol; 1971 Dec; 30(4):307-18. PubMed ID: 5135408
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and therapeutic evaluation of a new antilipemic substance].
    de Aguiar Magano L
    Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypolipaemic drugs and coronary heart disease.
    Howard AN
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209
    [No Abstract]   [Full Text] [Related]  

  • 12. Chlorophenoxyisobutyric acid derivatives and apolipoprotein B metabolism.
    Shepherd J; Packard CJ
    Monogr Atheroscler; 1985; 13():85-91. PubMed ID: 4088282
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical testing of a combination of clofibrate and beta-pyridylcarbinol in an unusual dosis relation].
    Mann S; Maisenbacher HJ
    Z Allgemeinmed; 1975 Aug; 51(24):1066-71. PubMed ID: 1101545
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of clofibrate on glucide tolerance in patients with ischemic heart disease and hyperlipoproteinemia].
    Bornemisza P; Csögör I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(6):543-6. PubMed ID: 34860
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
    Stähelin HB; Hartmann G
    Dtsch Med Wochenschr; 1974 Jun; 99(26):1392-4 passim. PubMed ID: 4601124
    [No Abstract]   [Full Text] [Related]  

  • 16. Type IV hyperlipoproteinemia. Clofibrate without dietary therapy.
    Zelis R; Amsterdam EA; Spann JF; Mason DT
    JAMA; 1972 Oct; 222(3):326-8. PubMed ID: 4566727
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of clofibrate and its derivative methyl clofenapate.
    Craig GM
    Atherosclerosis; 1972; 15(2):265-71. PubMed ID: 4666129
    [No Abstract]   [Full Text] [Related]  

  • 18. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract]   [Full Text] [Related]  

  • 19. [Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
    Kaffarnik H; Schneider J; Haase W
    Dtsch Med Wochenschr; 1975 Nov; 100(48):2486-8. PubMed ID: 1104303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altering lipid patterns in adult males.
    Appelbaum JJ; Amundsen MA; Perkin DK
    J Occup Med; 1974 Aug; 16(8):539-42. PubMed ID: 4367267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.